- Latest News
The Biomolecular Sciences Institute (BSI) at Florida International University invites applications to fill a full-time tenure-track faculty position to support continued growth of its biophysics and biochemistry programs.
The National Institutes of Health awarded BSI researchers nearly $2 million to study how targeting bacterial DNA can be used to kill antibiotic-resistant superbugs.
Ph.D. students mentored by BSI faculty have been extraordinarily successful in their career pursuits and have entered very diverse career paths both within and beyond academia.
Ms. Monica Rodriguez-Silva receives prestigious travel award to present research findings at the 2017 Annual Meeting of the American Society for Cell Biology (ASCB). Monica is a PH.D. candidate in Dr. Jeremy Chambers Lab for Mitochondrial Communication. Under his mentorship she studies how to characterize a variant of the mitochondrial scaffold Sab and she is interested in understanding how alternative splicing of Sab may be a means to regulate cellular responsiveness to mitochondrial health.
Congratulations to all BSI faculty who were recognized at the 2017 FIU Inventor's Recognition Reception!
Congratulations to the BSI faculty who were awarded at the 2017 Faculty Convocation Award Ceremony.
CASE Awards honor our dedicated faculty for their exceptional work in research, teaching, service and engagement. Congratulations to all of our BSI faculty who were honored!
BSI researchers receive funding for research relevant for finding new antibiotics to treat superbugs
Researchers at the Biomolecular Sciences Institute have been awarded over $1.7M from NIH to research that can lead to more effective ways to combat superbugs.
Congratulations to BSI Members- Jessica Ramella-Roman, Arvind Agarwal, Chenzhong Li, and Jin He on driving healthcare innovations through the newly establised Engineering Research Center (ERCs)!
Dr. Yuk-Ching Tse-Dinh's research investigates the structure and function of DNA topoisomerases as the basis of discovery for antibacterial and anticancer drug leads from synthetic molecules and natural products. With her grant renewal she will continue to focus on understanding the structure, mechanism, interactions and regulation of bacterial topoisomerase I, a validated target for discovery of novel antibacterial compounds.